Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MH

Go back to Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
(NASDAQ: LEXX) Delayed: 0.61 -0.03 (4.69%)
Previous Close $0.64    52 Week High $ 
Open $0.64    52 Week Low $ 
Day High $0.65    P/E N/A 
Day Low $0.61    EPS $ 
Volume 93,275